NEOGEN CORP (NEOG) Form 10-K Annual Reports
NEOGEN CORP (NEOG) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NEOG
CIK: 711377
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 05/31
State: MI
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 5/31/2026 12:00:00 AM
Lead Engagement PartnerChristopher Hickmann
Audit LocationGrand Rapids, Michigan, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-10-09 | PRIMARY DOCUMENT | 0000711377-26-000029 | View SEC Doc Filr Page |
| 10-Q | 2026-10-07 | 2026-08-31 | 10-Q | 0001193125-26-416954 | View SEC Doc Filr Page |
| 8-K | 2026-10-07 | 2026-10-01 | 8-K | 0001193125-26-416247 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001193125-26-415544 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000028 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000026 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000021 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-28 | — | DEFA14A | 0001193125-26-403465 | View SEC Doc Filr Page |
| ARS | 2026-08-21 | 2026-05-31 | ARS | 0001193125-26-360755 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-21 | — | DEFA14A | 0001193125-26-360749 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-21 | 2026-08-21 | DEF 14A | 0001193125-26-360742 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | PRIMARY DOCUMENT | 0000711377-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | PRIMARY DOCUMENT | 0000711377-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | PRIMARY DOCUMENT | 0000711377-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | PRIMARY DOCUMENT | 0000711377-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | PRIMARY DOCUMENT | 0000711377-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | PRIMARY DOCUMENT | 0000711377-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | PRIMARY DOCUMENT | 0000711377-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-03 | 8-K | 0001193125-26-340216 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | PRIMARY DOCUMENT | 0000711377-26-000013 | View SEC Doc Filr Page |